Sippl W - Search Results

1

Selective degradation of mutant FMS-like tyrosine kinase-3 requires BIM-dependent depletion of heat shock proteins.

Halilovic M, Abdelsalam M, Zabkiewicz J, Lazenby M, Alvares C, Schmidt M, Brenner W, Najafi S, Oehme I, Hieber C, Zeyn Y, Bros M, Sippl W, Krämer OH. Halilovic M, et al. Among authors: sippl w. Leukemia. 2024 Dec;38(12):2561-2572. doi: 10.1038/s41375-024-02405-5. Epub 2024 Sep 17. Leukemia. 2024. PMID: 39300221 Free PMC article.

2

First total synthesis of 1,2-dipalmitoyl-3-(N-palmitoyl-6'-amino-6'-deoxy-alpha-D-glucosyl)-sn-glycerol--a glycoglycerolipid of a marine alga with a high inhibitor activity against human Myt1-kinase.

Göllner C, Philipp C, Dobner B, Sippl W, Schmidt M. Göllner C, et al. Among authors: sippl w. Carbohydr Res. 2009 Sep 8;344(13):1628-31. doi: 10.1016/j.carres.2009.05.022. Epub 2009 Jun 2. Carbohydr Res. 2009. PMID: 19555926

3

In vitro and in silico studies on substrate recognition and acceptance of human PKMYT1, a Cdk1 inhibitory kinase.

Rohe A, Erdmann F, Bäßler C, Wichapong K, Sippl W, Schmidt M. Rohe A, et al. Among authors: sippl w. Bioorg Med Chem Lett. 2012 Jan 15;22(2):1219-23. doi: 10.1016/j.bmcl.2011.11.064. Epub 2011 Nov 23. Bioorg Med Chem Lett. 2012. PMID: 22189141

4

Evaluation of potential Myt1 kinase inhibitors by TR-FRET based binding assay.

Rohe A, Göllner C, Wichapong K, Erdmann F, Al-Mazaideh GM, Sippl W, Schmidt M. Rohe A, et al. Among authors: sippl w. Eur J Med Chem. 2013 Mar;61:41-8. doi: 10.1016/j.ejmech.2012.06.007. Epub 2012 Jun 12. Eur J Med Chem. 2013. PMID: 22770610

5

A fluorescence anisotropy-based Myt1 kinase binding assay.

Rohe A, Henze C, Erdmann F, Sippl W, Schmidt M. Rohe A, et al. Among authors: sippl w. Assay Drug Dev Technol. 2014 Mar;12(2):136-44. doi: 10.1089/adt.2013.534. Epub 2013 Nov 14. Assay Drug Dev Technol. 2014. PMID: 24229357

6

Application of docking and QM/MM-GBSA rescoring to screen for novel Myt1 kinase inhibitors.

Wichapong K, Rohe A, Platzer C, Slynko I, Erdmann F, Schmidt M, Sippl W. Wichapong K, et al. Among authors: sippl w. J Chem Inf Model. 2014 Mar 24;54(3):881-93. doi: 10.1021/ci4007326. Epub 2014 Feb 13. J Chem Inf Model. 2014. PMID: 24490903

7

The glycoglycerolipid 1,2-dipalmitoyl-3-(N-palmitoyl-6'-amino-6'-deoxy-α-d-glucosyl)-sn-glycerol is no inhibitor of the human Myt1 kinase.

Rohe A, Göllner C, Erdmann F, Sippl W, Schmidt M. Rohe A, et al. Among authors: sippl w. J Enzyme Inhib Med Chem. 2015 Jun;30(3):514-7. doi: 10.3109/14756366.2014.926343. Epub 2014 Jun 18. J Enzyme Inhib Med Chem. 2015. PMID: 24939100 Free article.

8

HDAC8: a multifaceted target for therapeutic interventions.

Chakrabarti A, Oehme I, Witt O, Oliveira G, Sippl W, Romier C, Pierce RJ, Jung M. Chakrabarti A, et al. Among authors: sippl w. Trends Pharmacol Sci. 2015 Jul;36(7):481-92. doi: 10.1016/j.tips.2015.04.013. Epub 2015 May 23. Trends Pharmacol Sci. 2015. PMID: 26013035 Free article. Review.

9

Identification of peptidic substrates for the human kinase Myt1 using peptide microarrays.

Rohe A, Platzer C, Masch A, Greiner S, Henze C, Ihling C, Erdmann F, Schutkowski M, Sippl W, Schmidt M. Rohe A, et al. Among authors: sippl w. Bioorg Med Chem. 2015 Aug 1;23(15):4936-4942. doi: 10.1016/j.bmc.2015.05.021. Epub 2015 May 19. Bioorg Med Chem. 2015. PMID: 26059593

10

Synthesis and Biological Investigation of Oxazole Hydroxamates as Highly Selective Histone Deacetylase 6 (HDAC6) Inhibitors.

Senger J, Melesina J, Marek M, Romier C, Oehme I, Witt O, Sippl W, Jung M. Senger J, et al. Among authors: sippl w. J Med Chem. 2016 Feb 25;59(4):1545-55. doi: 10.1021/acs.jmedchem.5b01493. Epub 2015 Dec 22. J Med Chem. 2016. PMID: 26653328

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

294 results

Search Page

Filters